ArticleInflammation research : official journal of the European Histamine Research Society ... [et al.]2026
Repetitive transcranial magnetic stimulation modulates neuroinflammation and cell apoptosis via the interaction between Ifit3 and Stat1 for the treatment of neuropathic pain.
Article in Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Focusing on inflammation-driven pyroptosis in postherpetic neuralgia: from molecular mechanisms to therapeutic strategies.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
objectiveRepetitive transcranial magnetic stimulation (rTMS), a non-invasive electrophysiological technique employed in the treatment of neuropathic pain (NeuP), still has an elusive therapeutic mechanism.
methodsIn this study, transcriptomic and proteomic analyses were carried out on the brain tissues of rats with chronic constriction injury (CCI) models. Particular emphasis was placed on the key regulatory molecule Ifit3 and its interacting protein Stat1.
resultsFindings revealed that rTMS was capable of significantly ameliorating the elevated expression levels of Ifit3 and Stat1 in the brain tissues of NeuP rats. Moreover, in in-vitro experiments, rTMS effectively mitigated the neuroinflammatory response and the degree of microglial apoptosis. Further investigations demonstrated that overexpressing Ifit3 led to an exacerbation of the aforementioned inflammation and apoptosis related manifestations. Conversely, silencing Ifit3 had a mitigating effect. Additionally, a high degree of consistency was observed in the expression changes of Stat1 and Ifit3.
conclusionsCollectively, these research outcomes indicate that rTMS exerts its therapeutic effect on NeuP by modulating the inflammatory response and cell apoptosis. During this process, the interaction between Ifit3 and Stat1 assumes a pivotal regulatory role.
Indexed as
Identifiers
41865234What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.